Kamiren Xl

Doxazosin, the active ingredient in Kamiren Xl, is a Alpha-1 adrenergic blocker presented as a tablet for oral use. It is employed to lower elevated blood pressure and to alleviate urinary obstruction caused by benign prostatic hyperplasia in adult patients.

GNH USA supplies Kamiren Xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Doxazosin acts on the alpha‑1 adrenergic pathway to manage vascular and prostatic smooth‑muscle tone. It is clinically employed for the following conditions: - Hypertension: lowers systemic blood pressure by vasodilation. - Benign prostatic hyperplasia (BPH): improves urinary flow by relaxing prostate and bladder neck smooth muscle. - Lower urinary tract symptoms due to BPH: reduces urgency, frequency and nocturia, enhancing quality of life.

Doxazosin may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially on standing. - Headache: mild to moderate intensity. - Fatigue: generalized tiredness. - Nasal congestion: stuffy nose. - Peripheral edema: swelling of ankles or feet. - Nausea: upset stomach.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Syncope: sudden loss of consciousness. - Heart failure exacerbation: worsening of pre‑existing cardiac insufficiency. - Hepatic injury: abnormal liver function tests. - Allergic reactions: rash, pruritus, or angioedema. - Priapism: prolonged painful erection.

Before initiating therapy with Doxazosin, consider the following safety measures: - Blood pressure monitoring: check baseline and periodic readings. - Renal function assessment: evaluate creatinine clearance in patients with kidney disease. - Orthostatic hypotension risk: advise slow position changes, especially in the elderly. - Concomitant antihypertensives: adjust doses to avoid excessive blood pressure fall. - Discontinuation: taper gradually rather than abrupt stop to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other alpha‑blockers: additive vasodilatory effect may cause severe hypotension. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase plasma concentrations, raising risk of adverse events. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may precipitate profound hypotension.

Moderate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response. - Diuretics: enhance orthostatic blood pressure changes. - Beta‑blockers: combined effect on heart rate and blood pressure requires observation. - CYP3A4 inducers (e.g., rifampin): may reduce doxazosin levels, diminishing efficacy.